日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming.

5-氮胞苷吸入干粉制剂通过基因组重编程显著改善肺癌治疗的药代动力学和疗效

Kuehl Philip J, Tellez Carmen S, Grimes Marcie J, March Thomas H, Tessema Mathewos, Revelli David A, Mallis Larry M, Dye Wendy W, Sniegowski Tyler, Badenoch Aaron, Burke Michael, Dubose Devon, Vodak David T, Picchi Maria A, Belinsky Steven A